Speaker(s): 

Sammie Zou PharmD Candidate, Wilkes University - has nothing to disclose.

Moderator(s): 

Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose

Faith Wellings PharmD, Wilkes University - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1.  Discuss classifications of lupus and diagnosis of drug-induced lupus erythematosus (DILE).

2. List common drugs associated with DILE along with other possible causes.

3. Discuss treatment strategies to manage and prevent DILE.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None